These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28951629)

  • 1. Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Dong X; Hou Q; Chen Y; Wang X
    Dis Markers; 2017; 2017():2929381. PubMed ID: 28951629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection.
    Dong X; He H; Zhang W; Yu D; Wang X; Chen Y
    Diagn Pathol; 2015 Aug; 10():133. PubMed ID: 26238200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
    Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K
    Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined detection of insulin-like growth factor-binding protein 7 promoter methylation improves the diagnostic efficacy of AFP in hepatitis B virus-associated hepatocellular carcinoma.
    Tao LP; Fan XP; Fan YC; Zhao J; Gao S; Wang K
    Pathol Res Pract; 2018 Jan; 214(1):144-150. PubMed ID: 29108923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of secreted frizzled related protein 2 gene promoter serves as a noninvasive biomarker for HBV-associated hepatocellular carcinoma.
    Xiang L; Chen LM; Zhai YJ; Sun WJ; Yang JR; Fan YC; Wang K
    Life Sci; 2021 Apr; 270():119061. PubMed ID: 33454364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
    Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of the Hypomethylation of the WISP1 Promoter in Patients with Hepatocellular Carcinoma Associated with Hepatitis B Virus.
    Chen LM; Xiang L; Sun WJ; Zhai YJ; Gao S; Fan YC; Wang K
    Tohoku J Exp Med; 2020 Dec; 252(4):297-307. PubMed ID: 33239483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma.
    Teng Y; Fan YC; Mu NN; Zhao J; Sun FK; Wang K
    Neoplasma; 2016; 63(3):419-26. PubMed ID: 26925788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B.
    Tian MM; Fan YC; Zhao J; Gao S; Zhao ZH; Chen LY; Wang K
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):171-180. PubMed ID: 28189396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
    Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
    Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma.
    Ji XF; Fan YC; Gao S; Yang Y; Zhang JJ; Wang K
    World J Gastroenterol; 2014 Apr; 20(16):4723-9. PubMed ID: 24782625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yu F; Lu Z; Chen B; Dong P; Zheng J
    Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma.
    Han LY; Fan YC; Mu NN; Gao S; Li F; Ji XF; Dou CY; Wang K
    Int J Med Sci; 2014; 11(2):164-71. PubMed ID: 24465162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RASSF1A and SOCS1 genes methylation status as a noninvasive marker for hepatocellular carcinoma.
    Pasha HF; Mohamed RH; Radwan MI
    Cancer Biomark; 2019; 24(2):241-247. PubMed ID: 30689554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection.
    Zhang F; Fan YC; Mu NN; Zhao J; Sun FK; Zhao ZH; Gao S; Wang K
    J Viral Hepat; 2014 Apr; 21(4):241-50. PubMed ID: 24597692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
    Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma.
    Liu HH; Fang Y; Wang JW; Yuan XD; Fan YC; Gao S; Han LY; Wang K
    Medicine (Baltimore); 2020 May; 99(20):e20326. PubMed ID: 32443384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
    Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
    Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Dou CY; Fan YC; Cao CJ; Yang Y; Wang K
    Dig Dis Sci; 2016 Apr; 61(4):1130-8. PubMed ID: 26660680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.